FDA NDC Directory · JSON-LD · Markdown

Ziprasidone Hydrochloride

NDC 68001-453 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA204117
Dosage form / routeCAPSULE · ORAL
Active ingredientsZIPRASIDONE HYDROCHLORIDE (80 mg/1)
Marketing started20200831
Package count1

External sources

Source: openFDA. Public-domain (CC0).